Stay updated on INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies

Sign up to get notified when there's something new on the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page.
Latest website image capture
Clouds background image

Latest updates to the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Expanded the Locations section with a comprehensive list of sites across the US, Canada, Australia, and Europe (e.g., Alabama, Ontario, Lombardy, Veneto, etc.) and updated the Last Update Posted field to reflect the new revision (v3.3.3). Some prior location blocks were removed.
    Difference
    1%
    Check dated 2025-12-19T14:10:18.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Added Vall d'Hebron Institute of Oncology (VHIO) in Barcelona as a study site. The VHIO site is listed as Withdrawn.
    Difference
    0.2%
    Check dated 2025-12-12T07:45:05.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2; this appears to be a minor update without changes to study details or user-facing content.
    Difference
    0.0%
    Check dated 2025-11-28T01:31:04.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Page revision label updated from v3.2.0 to v3.3.1.
    Difference
    0.0%
    Check dated 2025-11-20T22:42:56.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    FoundationOne®Liquid CDx diagnostic test has been added to identify genomic alterations for cohort assignment, and new arm details (including Inavolisib + Bevacizumab) with dosing information have been introduced. A new site location in Tainan, Taiwan (00704) and the KRAS G12C biomarker have been added to the study materials, with Hoffmann-La Roche listed as sponsor.
    Difference
    2%
    Check dated 2025-11-13T17:03:00.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    Minor non-substantive updates are visible (such as updated last updated date and small adjustments to the locations list), while core study content—design, arms, primary/secondary outcomes, and eligibility criteria—remains unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-30T11:24:45.000Z thumbnail image

Stay in the know with updates to INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies

Enter your email address, and we'll notify you when there's something new on the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page.